1187431-43-1,
Trametinib DMSO solvate,
Trametinib DMSO,
TRAMETINIB DIMETHYL SULFOXIDE,
UNII-BSB9VJ5TUT,
Trametinib (DMSO solvate),
GSK1120212B,
CHEBI:75991,
BSB9VJ5TUT,
Mekinst,
Mekinist (TN),
Trametinib dimethyl sulfoxide [USAN],
SCHEMBL1516331,
CHEMBL2105741,
DTXSID30152223,
OQUFJVRYDFIQBW-UHFFFAOYSA-N,
C26H23FIN5O4.C2H6OS,
AOB87798,
BCP06093,
KS-00000LF6,
4126AH,
GSK 1120212B,
GSK-1120212B,
HY-10999A,
MFCD21609250,
AKOS027338667,
CS-0061,
AK340973,
AS-17069,
Trametinib dimethyl sulfoxide (JAN/USAN),
FT-0696678,
D10176,
W-5848,
J-524976,
Acetamide, N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-3,4,6,7-tetrahydro-6,8- dimethyl-2,4,7-trioxopyrido(4,3-d)pyrimidin-1(2H)-yl)phenyl)-, compd. with 1,1'- sulfinylbis(methane) (1:1),
Equimolecular combination of N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8- dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido(4,3-d)pyrimidin-1(2H)- yl)phenyl)acetamide with dimethyl-lambda(sup 4)-sulfanone,
N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide compound with (methylsulfinyl)methane (1:,
N-(3-(3-Cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide compound with (methylsulfinyl)methane (1:1),
N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-1H,2H,3H,4H,6H,7H-pyrido[4,3-d]pyrimidin-1-yl}phenyl)acetamide; methanesulfinylmethane,
N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide--(methylsulfinyl)methane (1/1),
N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide;methylsulfinylmethane,
Trametinib,
Mekinist,
GSK1120212,
JTP 74057,
GSK-1120212 DMSO solvate,
ACN-041326,
GSK-1120212,
A3887,
GSK-1120212 DMSO solvate;Trametinib;JTP-74057;GSK-1120212;GSK1120212;GSK 1120212;JTP 74057;JTP74057,